Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
Haverkos B, Alpdogan O, Baiocchi R, Brammer JE, Feldman TA, Capra M, Brem EA, Nair S, Scheinberg P, Pereira J, Shune L, Joffe E, Young P, Spruill S, Katkov A, McRae R, Royston I, Faller DV, Rojkjaer L, Porcu P. Haverkos B, et al. Among authors: alpdogan o. Blood Adv. 2023 Oct 24;7(20):6339-6350. doi: 10.1182/bloodadvances.2023010330. Blood Adv. 2023. PMID: 37530631 Free PMC article. Clinical Trial.
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Oluwasanjo A, Kartan S, Johnson W, Alpdogan O, Gru A, Mishra A, Haverkos BM, Gong J, Porcu P. Oluwasanjo A, et al. Among authors: alpdogan o. Cancer Treat Res. 2019;176:83-98. doi: 10.1007/978-3-319-99716-2_4. Cancer Treat Res. 2019. PMID: 30596214 Review.
Systemic therapy of cutaneous T-cell lymphoma (CTCL).
Alpdogan O, Kartan S, Johnson W, Sokol K, Porcu P. Alpdogan O, et al. Chin Clin Oncol. 2019 Feb;8(1):10. doi: 10.21037/cco.2019.01.02. Chin Clin Oncol. 2019. PMID: 30818958 Free article. Review.
The Two-Step Allogeneic Stem Cell Transplantation Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies.
Yang Y, Gergis U, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Binder A, Alpdogan O, Martinez-Outschoorn U, Porcu P, Flomenberg N, Grosso D. Yang Y, et al. Among authors: alpdogan o, o hara w. Transplant Cell Ther. 2022 Mar;28(3):159.e1-159.e5. doi: 10.1016/j.jtct.2021.12.013. Epub 2021 Dec 24. Transplant Cell Ther. 2022. PMID: 34954295 Free article.
Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination.
Gung C, McGuire R, George M, Abdulkareem A, Belden KA, Porcu P, Martinez-Outschoorn U, Binder AF, Chervenova I, Alpdogan O. Gung C, et al. Among authors: alpdogan o. Front Oncol. 2022 Jul 7;12:840451. doi: 10.3389/fonc.2022.840451. eCollection 2022. Front Oncol. 2022. PMID: 35875166 Free PMC article.
Special Considerations in the Treatment of Mycosis Fungoides.
Duffy R, Jennings T, Kartan S, Song A, Shi W, Porcu P, Alpdogan O, Sahu J. Duffy R, et al. Among authors: alpdogan o. Am J Clin Dermatol. 2019 Aug;20(4):571-578. doi: 10.1007/s40257-019-00431-z. Am J Clin Dermatol. 2019. PMID: 30993584
95 results